Bacterial vaccine
AssigneeBellevacc AS
InventorHenning Sørum
Life of this patent
Estimating the term…
Abstract
The present document discloses a method for producing a bacterial vaccine composition against bacterial diseases in animals, such as tetrapods or fish, wherein said bacterial vaccine composition comprises inactivated bacteria of the bacterium causing said bacterial diseases. The method involves exposing the bacteria to different growth conditions and then preparing a bacterial vaccine composition where the bacteria are exposed to different growth conditions. With vaccines prepared by the present method, bacterial diseases that previously had not been able to be cured could be treated or the effect of the treatment was more long-lasting.
Claims16
A method for producing a bacterial vaccine composition against a bacterial disease in a tetrapod and/or a fish, wherein said bacterial vaccine composition comprises inactivated bacteria of the bacterium causing said bacterial disease, said method comprising:
- i) preparing cultures A, B, C, D, F, G and H, or preparing all of cultures A to H, wherein:
- culture A is prepared by first preparing a pre-culture “a” by inoculating said bacterium in 0.5 to 3.5% NaCl, and incubating before transferring said pre-culture “a” to a nutrient-rich bacterial growth medium with 0.5% to 3.5% NaCl, and incubating under microaerophilic conditions to prepare culture A;
- culture B is prepared by first preparing a pre-culture “a” by inoculating said bacterium in 0.5 to 3.5% NaCl and incubating before transferring said pre-culture “a” to cell culture medium for fish or mammalian cells, and incubating under microaerophilic conditions to prepare culture B;
- culture C is prepared by first preparing a pre-culture “b” by inoculating said bacterium in a cell culture medium for fish or mammalian cells, and incubating before transferring said pre-culture “b” to a solution typically comprising about 0.5 to 15% (w/v) gelatin with 0.05 to 1.5% glucose and incubating under microaerophilic conditions to prepare culture C;
- culture D is prepared by first preparing a pre-culture “c” by inoculating said bacterium in blood, plasma or serum and incubating before transferring said pre-culture “c” to brain heart infusion medium with 0.05 to 1.5% glucose and incubating under microaerophilic conditions to prepare culture D;
- culture E is prepared by inoculating said bacterium in enrichment broth and incubating under aerobic conditions to prepare culture E;
- culture F is prepared by transferring bacteria from culture E or from enrichment medium containing for example blood, plasma and/or serum to 0.5 to 3.5% NaCl;
- culture G is prepared by transferring bacteria from culture E or from enrichment medium containing for example blood, plasma and/or serum, to a cell culture medium for fish or mammalian cells;
- culture H is prepared by transferring bacteria from culture E or from enrichment medium containing for example blood, plasma and/or serum to blood or plasma serum;
- ii) inactivating the bacteria of the prepared cultures;
- iii) optionally washing the inactivated cultures of step ii);
- and
- iv) mixing the optionally washed and resuspended inactivated cultures to prepare the bacterial vaccine composition;
- wherein step iv) of mixing optionally may be performed before step ii) or before step iii) instead of after step iii).
Dependencies are inferred from the claim text.